Dfpg Investments, LLC Arcturus Therapeutics Holdings Inc. Transaction History

Dfpg Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 14, 2021	SELL	$38.75 - $86.92 $3.45 Million - $7.74 Million	-89,004 Closed	0 $0
Q4 2020 Jan 19, 2021	SELL	$34.61 - $123.66 $3.28 Million - $11.7 Million	-94,799 Reduced 51.58%	89,004 $5.75 Million
Q3 2020 Oct 13, 2020	SELL	$37.49 - $63.19 $782,416 - $1.32 Million	-20,870 Reduced 10.2%	183,803 $9.36 Million
Q2 2020 Jul 13, 2020	SELL	$12.66 - $58.27 $1.42 Million - $6.53 Million	-112,111 Reduced 35.39%	204,673 $10.2 Million
Q1 2020 Apr 17, 2020	SELL	$9.31 - $18.26 $1.3 Million - $2.55 Million	-139,606 Reduced 30.59%	316,784 $5.7 Million
Q4 2019 Feb 04, 2020	SELL	$8.93 - $12.41 $36,255 - $50,384	-4,060 Reduced 0.88%	456,390 $5.54 Million
Q3 2019 Oct 15, 2019	BUY	$8.8 - $14.5 $4.05 Million - $6.68 Million	460,450 New	460,450 $4.8 Million

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $439M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Dfpg Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Dfpg Investments, LLC with notifications on news.